HULL ANDREW
SEC CIK 1818252 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| INM | InMed Pharmaceuticals Inc. | Dir | 38.3K | $14.6K | — | 1 | 2024-02-21 | 2024-02-21 |
Most active insiders at INM, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | ADAR1 Capital Management, LLC | 10% | $841.2K | — |
| 2 | Vivo Opportunity, LLC | 10% | $433.5K | — |
HULL ANDREW made no open-market trades at INM in the last 12 months.
Transactions 1
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-02-22 | 2024-02-21 | INM | InMed Pharmaceuticals Inc. | HULL ANDREW | Dir | P - Purchase | $0.39 | +37.5K | 38.3K | +4,947% | +$14.6K |
Purchase Sale Sale after option exercise All abbreviations